Long-Term Follow-Up Roadmaps by Disease and Treatment
Chemotherapy Dose Late effect Baseline screening Anthracycline ≥300 mg/m2 or Cardiomyopathy valvular, pericardial damage, coronary artery disease EKG, ECHO (Doxorubicin >200 mg/m2 + Daunorubicin Chest XRT ≥30 Gy Epirubicin HD…